| Description |
1 online resource (ix, 296 pages) : illustrations |
| Series |
Novartis Foundation symposium ; 257 |
|
Novartis Foundation symposium ; 257.
|
| Contents |
History and classification of anaphylaxis / Johannes Ring, Knut Brockow and Heidrun Behrendt -- Rethinking Th2 antibody responses and allergic sensitization / Debra Stern, Waltraud Eder, Gina Tebow, I. Carla Lohman, Elisa Soprana, Charlotte Braun-Fahrländer, Josef Riedler, Dennis Nowak, Erika Von Mutius, Marilyn Halonen and Donata Vercelli -- The high anity receptor for IgE, Fc[epsilon]RI / Henry Metzger -- Effector cells of anaphylaxis : mast cells and basophils / Lawrence B. Schwartz -- Cytokine enhancement of anaphylaxis / Richard Strait, Suzanne C. Morris and Fred D. Finkelman -- Patterns of anaphylaxis : acute and late phase features of allergic reactions / David B.K. Golden -- Fatal anaphylaxis in the UK, 1992-2001 / Richard S.H. Pumphrey -- The human heart as a shock organ in anaphylaxis / Gianni Marone, Maria Bova, Aikaterini Detoraki, Anna Maria Onorati, Francesca W. Rossi and Giuseppe Spadaro -- Food-induced anaphylaxis / Hugh A. Sampson -- Anaphylaxis to insect venom / Holger Mosbech -- Anaphylaxis to anaesthetic drugs / Malcolm Fisher -- The radiocontrast molecule in anaphylaxis : a surprising antigen / Elliott C. Lasser -- Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis / F. Estelle R. Simons -- New approaches for the treatment of anaphylaxis / Donald Y.M. Leung, William R. Shanahan, Xiu-Min Li and Hugh A. Sampson -- Patient's perspective and public policy regarding anaphylaxis / Anne Muñoz-Furlong |
| Summary |
Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anap |
| Analysis |
Novartis |
| Notes |
"Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents page |
| Bibliography |
Includes bibliographical references and indexes |
| Notes |
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL |
|
Print version record |
|
digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL |
| Subject |
Anaphylaxis.
|
|
Anaphylaxis -- Diagnosis
|
|
Anaphylaxis -- Treatment
|
|
Anaphylaxis
|
|
MEDICAL -- Immunology.
|
|
HEALTH & FITNESS -- Allergies.
|
|
HEALTH & FITNESS -- Diseases -- Immune System.
|
|
Anaphylaxis
|
| Genre/Form |
proceedings (reports)
|
|
Conference papers and proceedings
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
| Form |
Electronic book
|
| Author |
Bock, Gregory
|
|
Goode, Jamie
|
|
Novartis Foundation.
|
| ISBN |
0470861150 |
|
9780470861158 |
|
0470861142 |
|
9780470861141 |
|
0470861193 |
|
9780470861196 |
|
